Mus vs Saudi Arabia: Estimated antiretroviral therapy coverage among people living with HIV
Mus
36.0%
in 2025
Saudi Arabia
97.0%
in 2025
Mus rank
2nd
Saudi Arabia rank
2nd
Estimated antiretroviral therapy coverage among people living with HIV over time
- Mus
- Saudi Arabia
How they compare
Saudi Arabia currently reports 97.0% against 36.0% in Mus, a difference of 61.0%.
That makes Saudi Arabia's figure about 2.7 times Mus's.
Across all 26 years both countries report, Saudi Arabia has been ahead every year.
Mus ranks 2nd and Saudi Arabia ranks 2nd of 2 regions.
Saudi Arabia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Mus | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.9% | 36.2% | 33.3% | Saudi Arabia |
| 2010s | 20.5% | 50.3% | 29.8% | Saudi Arabia |
| 2020s | 30.7% | 86.2% | 55.5% | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Mus or Saudi Arabia?
- Saudi Arabia, at 97.0% against 36.0% in Mus as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Mus and Saudi Arabia?
- 61.0%, with Saudi Arabia ahead.
- How many years of comparable data are there for Mus and Saudi Arabia?
- 26 years are reported by both, from 2000 to 2025.
- How do Mus and Saudi Arabia rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Mus ranks 2nd and Saudi Arabia ranks 2nd of 2 regions.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.